Zimmer Biomet stock falls around 3.5% as sellers maintain firm control

Traders Union
All News
Stocks
Zimmer Biomet slides 3.53% today

Highlights

Zimmer Biomet stock draws income-focused attention ahead of its late September ex-dividend date.
Shares closed about 10.8% below the 52-week high amid mixed sector performance and persistent selling pressure.
The stock trades below key averages, with sellers controlling momentum and a five-day forecast range of $87.15 to $92.47.

Dividend anticipation fuels steady demand amid broad sector weakness

Zimmer Biomet Holdings Inc is drawing attention from income-focused investors ahead of its late September ex-dividend date. The stock recently closed around 10.8% below its 52-week high, with trading volumes near recent averages. Activity in the healthcare and medical devices sector was marked by mixed performance, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, believes Zimmer Biomet’s selloff is not just technical but also tied to persistent negative sentiment. The stock’s failure to hold above key moving averages underlines weak buyer conviction. Mixed sector performance and lack of strong institutional support compound the risk near the ex-dividend date. Downside momentum dominates as confirmed by MACD and intraday volume. "Selling pressure is likely to persist unless there is a sustained turnaround in both technical signals and market sentiment," Kharitonov warns.

Viktoras Karapetjanc, expert at Traders Union, sees opportunity in Zimmer Biomet’s temporary weakness. He highlights that institutional and income-focused interest is set to strengthen on the upcoming ex-dividend event. Despite short-term volatility, the bullish structure remains intact with the 50-day moving average holding above the 200-day. Karapetjanc notes the healthcare sector’s resilience despite overall market selling. "I expect investor demand to support a rebound soon, especially as the technical long-term setup favors further growth," he says.

Parshwa Turakhiya, analyst, observes short-term traders are responding to clear downside momentum and volatility spikes. He points out intraday weakness and a gap down, indicating sellers are firmly in control for now. Turakhiya suggests that swing opportunities may open if the price rebounds above $91.45 or breaks below $90.54 for further follow-through. "For now, sentiment remains cautious and setups favor capital protection until a decisive directional break occurs," he says.

Persistent downside momentum as technical signals confirm seller dominance

Zimmer Biomet is currently trading below its 20-day ($97.12), 50-day ($96.15), and 200-day ($91.45) moving averages, which signals persistent pressure from sellers across all timeframes. The near-term ceiling is set at $91.45 and the near-term floor aligns with today’s low at $90.54, while the long-term trend structure remains technically bullish due to the 50-day average sitting above the 200-day. Momentum signals are broadly negative: the Moving Average Convergence Divergence (MACD) and Relative Strength Index (RSI) both point to further selling, with the RSI of 43.59 flagging a biased-to-weak trend. The Commodity Channel Index (CCI) confirms the downside, and Bull/Bear Power (BBP) at -0.3 signals sellers dominate intraday, also registering an oversold reading; the Awesome Oscillator (AO) reinforces the bearish direction. The stock is down to $90.66, slipping 3.53% intraday after opening with a downside gap of approximately $1.38 or 1.47%. Price is trading near the intraday low with volatility amplitude at 2.99%, suggesting heavy pressure after the open. Short-term trends show little conflict among indicators as sellers control the session in line with the overall momentum profile.

Earlier, analysts noted that Zimmer Biomet’s technical momentum had turned positive after a period of weakness, highlighting a bullish setup if buyers could sustain control. However, the recent decisive move below key moving averages adds a new dimension by confirming that sellers now dominate, with $90.54 as the immediate downside level to watch for potential further declines.

Source of Data: ZBH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.